Paying Less for Drugs With Problematic Approvals? Paying Less for Drugs With Problematic Approvals?

The FDA ' s accelerated approval process has recently caused outrage; now some Medicaid experts suggest reducing payment until the clinical benefit of these drugs is proved in confirmatory trials.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news